John Johnson

John Johnson

Chairman at AUTOLUS THERAPEUTICS PLC

Net worth: 3 M $ as of 2024-02-28

66 year
Health Technology
Commercial Services
Technology Services

Profile

John joined HealthQuest in 2023 as an Operating Partner focused on the Tactical Opportunities Fund.
John is a recognized leader in the healthcare industry with more than three decades of experience across operating and investing.
He is currently Chief Executive Officer at Reaction Biology, a global CRO.
He previously was the Chief Executive Officer of Strongbridge Biopharma PLC.
prior to the merger with Xeris Biopharma.
John has held executive management roles at leading global corporations, including Johnson & Johnson, where he spent the majority of career and served as the Company Group Chairman of Biopharmaceuticals within Johnson & Johnson.
He was responsible for the Johnson & Johnson Biotechnology, Immunology and Oncology commercial businesses.
John also served as President of Eli Lilly & Company's Worldwide Oncology Unit, following the company's 2008 acquisition of Imclone Systems, Inc., where he served as Chief Executive Officer and a member of ImClone’s Board of Directors.
John has served on 18 boards and presently serves on 5 company boards including Reaction Biology, Axogen (AXGN), Xeris Pharmaceuticals (XERS), Verastem Oncology (VSTM) and Autolus Ltd (AUTL).
He served on two private equity backed company boards through successful exits, including most recently BioAgilytix and W2O.
He has also served as a member of the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA) and as a member of the Health Section Governing Board of Biotechnology Industry Organization (BIO).
John received his BS from East Stroudsburg University and MBA from University of Rochester, Simon Business School.
John and his wife have 4 children and 4 grandchildren.
In his free time, he enjoys golf, fishing, and archery.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-17 751,412 ( 0.54% ) 2 M $ 2024-02-28
2023-08-31 30,236 ( 0.07% ) 319 292 $ 2024-02-28
2023-02-28 0 ( -.--% ) - $ 2024-02-28
2024-03-10 0 ( -.--% ) - $ 2024-02-28

John Johnson active positions

CompaniesPositionStart
VERASTEM, INC. Director/Board Member 2020-04-22
AXOGEN, INC. Director/Board Member 2021-07-18
AUTOLUS THERAPEUTICS PLC Chairman 2021-09-14
XERIS BIOPHARMA HOLDINGS, INC. Director/Board Member 2021-10-04
Chief Executive Officer 2022-03-15
Cobepa North America, Inc. Consultant / Advisor -
Private Equity Investor 2022-12-31
Chairman 2015-11-08
Plum Brook Advisors LLC Founder 2014-07-31
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of John Johnson

Former positions of John Johnson

CompaniesPositionEnd
░░░░░░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of John Johnson's experience

Training of John Johnson

Rochester Christian University Masters Business Admin
East Stroudsburg University of Pennsylvania Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Johnson's experience

Connections

100 +

1st degree connections

40

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
JOHNSON & JOHNSON

Health Technology

ELI LILLY AND COMPANY

Health Technology

CORCEPT THERAPEUTICS INCORPORATED

Health Technology

VERASTEM, INC.

Health Technology

AXOGEN, INC.

Health Technology

CNS PHARMACEUTICALS, INC.

Health Technology

AUTOLUS THERAPEUTICS PLC

Health Technology

XERIS BIOPHARMA HOLDINGS, INC.

Health Technology

Private companies30

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Technology Services

Commercial Services

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Tranzyme Pharma, Inc. (Canada)

Technology Services

Commercial Services

Finance

Health Technology

Plum Brook Advisors LLC

Miscellaneous

Health Technology

Health Technology

Cobepa North America, Inc.

Finance

See company connections
  1. Stock
  2. Insiders
  3. John Johnson